Aims

To support the free and open dissemination of research findings and information on alcoholism and alcohol-related problems. To encourage open access to peer-reviewed articles free for all to view.

For full versions of posted research articles readers are encouraged to email requests for "electronic reprints" (text file, PDF files, FAX copies) to the corresponding or lead author, who is highlighted in the posting.

___________________________________________

Tuesday, July 20, 2010

Computational modeling study of human nicotinic acetylcholine receptor for developing new drugs in the treatment of alcoholism


Alcohol abuse and alcoholism are serious and costly problem in USA. Thus, the development of anti-alcoholism agents could be very significant.

The understanding of the neurochemical basis underlying the addictive properties of drugs of abuse is imperative for the development of new pharmacological means to reverse the addictive state, prevent relapse or to reduce the intake of addictive compounds. The nicotinic acetylcholine receptors (nAChRs) are important therapeutic targets for various diseases.

Recent studies have revealed that the α3β2, α3β3, and α6 subunits of nAChR protein family might be pharmacological targets for developing new drugs in the treatment of alcoholism.

We have performed computational homology modeling of the α3β2, α3β3, and α6 subunits of human nACHRs based upon the recently determined crystal structure of the extracellular domain (ECD) of the mouse nAChR α1 subunit complexed with α-bungarotoxin at 1.94 Å resolution.

For comparison, we also built the ECD models of α4β2, and α7 subunits of human nACHRs which are neurochemical targets for cessation of smoking. The three-dimensional (3D) models of the ECD of the monomer, and pentamer of these human nAChR were constructed.

The docking of the agonist in the ligand-binding pocket of the human nAChR dimers was also performed.

Since the nAChR ligand-binding site is a useful target for mutagenesis studies and the rational design of drugs against various diseases, these models provide useful information for future investigation.


Read Full Abstract


Request Reprint E-Mail: huzengjian@yahoo.com


__________________________________________